AstraZeneca plc (ADR) (NYSE:AZN)

CAPS Rating: 5 out of 5

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Recs

0
Player Avatar jmt587 (99.85) Submitted: 9/22/2011 2:10:02 PM : Outperform Start Price: $40.77 AZN Score: -16.64

Long Term Outperform.

Featured Broker Partners


Advertisement